Safety and efficacy of nivolumab in metastatic renal cell carcinoma (mRCC): Results from the NIVOREN GETUG-AFU 26 study.

被引：9
|
作者：
Albiges, Laurence
Negrier, Sylvie
Dalban, Cecile
Gravis, Gwenaelle
Chevreau, Christine
Oudard, Stephane
Laguerre, Brigitte
Barthelemy, Philippe
Borchiellini, Delphine
Gross-Goupil, Marine
Geoffrois, Lionnel
Brihoum, Meryem
Escudier, Bernard
机构：
[1] Univ Paris Sud, Gustave Roussy Inst Oncol, Villejuif, France
[2] Ctr Leon Berard, Lyon, France
[3] Inst Paoli Calmettes, Marseille, France
[4] IUCT Oncopole Inst Claudius Regaud, Toulouse, France
[5] AP HP, Hop Europeen Georges Pompidou, Paris, France
[6] Ctr Eugene Marquis, Rennes, France
[7] Hopitaux Univ Strasbourg, Strasbourg, France
[8] Ctr Antoine Lacassagne, Nice, France
[9] Ctr Hosp Univ St Andre, Bordeaux, France
[10] Inst Cancerol Lorraine, Vandoeuvre Les Nancy, France
[11] UNICANCER, Paris, France
[12] Gustave Roussy Canc Campus, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.577
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
577
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Is body mass index (BMI) associated with favorable outcomes in metastatic renal cell carcinoma (mRCC) treated with nivolumab? An ancillary study of the NIVOREN-GETUG AFU-26 trial
    Colomba, Emeline
    Dalban, Cecile
    Flechon, Aude
    Chevreau, Christine
    Gravis, Gwenaelle
    Thibault, Constance
    Laguerre, Brigitte
    Barthelemy, Philippe
    Borchiellini, Delphine
    Goupil, Marine Gross
    Geoffrois, Lionnel
    Rolland, Frederic
    Thiery-Vuillemin, Antoine
    Joly, Florence
    Ladoire, Sylvain
    Tantot, Florence
    Escudier, Bernard
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [22] NIVOREN GETUG-AFU 26 translational study: Association of PD-1, AXL, and PBRM-1 with outcomes in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) treated with nivolumab (N)
    Vano, Yann-Alexandre
    Rioux-Leclercq, Nathalie
    Dalban, Cecile
    Sautes-Fridman, Catherine
    Bougouin, Antoine
    Chaput, Nathalie
    Chouaib, Salem
    Beuselinck, Benoit
    Chevreau, Christine
    Gross-Goupil, Marine
    Negrier, Sylvie
    Laguerre, Brigitte
    Borchiellini, Delphine
    Colina-Moreno, Irelka
    Fridman, Wolf-Herman
    Chabaud, Sylvie
    Tantot, Florence
    Monteiro, Janice Barros
    Escudier, Bernard
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [23] NIVOREN GETUG-AFU 26 translational study: CD8 infiltration and PD-L1 expression are associated with outcome in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) treated with nivolumab (N)
    Vano, Y.
    Rioux-Leclercq, N.
    Dalban, C.
    Sautes-Fridman, C.
    Bougouin, A.
    Chaput, N.
    Chouaib, S.
    Beuselinck, B.
    Chevreau, C. M.
    Gross-Goupil, M.
    Negrier, S.
    Laguerre, B.
    Borchiellini, D.
    Colina-Moreno, I.
    Fridman, W. H.
    Chabaud, S.
    Tantot, F.
    Monteiro, J. Barros
    Escudier, B.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2019, 30 : 360 - +
  • [24] Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial
    Billon, Emilien
    Dalban, Cecile
    Oudard, Stephane
    Chevreau, Christine
    Laguerre, Brigitte
    Barthelemy, Philippe
    Borchiellini, Delphine
    Geoffrois, Lionnel
    Negrier, Sylvie
    Joly, Florence
    Thiery-Vuillemin, Antoine
    Gross-Goupil, Marine
    Rolland, Frederic
    Priou, Frank
    Mahammedi, Hakim
    Tantot, Florence
    Escudier, Bernard
    Chabaud, Sylvie
    Albiges, Laurence
    Gravis, Gwenaelle
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (04): : 742 - 750
  • [25] Association of adrenal metastases with outcomes in patients with metastatic clear cell renal cell carcinoma (mccRCC) treated with nivolumab in the GETUG-AFU-26 NIVOREN phase II trial.
    Billon, Emilien
    Dalban, Cecile
    Oudard, Stephane
    Chevreau, Christine
    Laguerre, Brigitte
    Barthelemy, Philippe
    Borchiellini, Delphine
    Geoffrois, Lionnel
    Negrier, Sylvie
    Joly, Florence
    Thiery-Vuillemin, Antoine
    Gross-Goupil, Marine
    Rolland, Frederic
    Priou, Frank
    Mahammedi, Hakim
    Tantot, Florence
    Escudier, Bernard
    Chabaud, Sylvie
    Albiges, Laurence
    Gravis, Gwenaelle
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [26] Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study
    Carril-Ajuria, Lucia
    Desnoyer, Aude
    Meylan, Maxime
    Dalban, Cecile
    Naigeon, Marie
    Cassard, Lydie
    Vano, Yann
    Rioux-Leclercq, Nathalie
    Chouaib, Salem
    Beuselinck, Benoit
    Chabaud, Sylvie
    Barros-Monteiro, Janice
    Bougouin, Antoine
    Lacroix, Guillaume
    Colina-Moreno, Irelka
    Tantot, Florence
    Boselli, Lisa
    De Oliveira, Caroline
    Fridman, Wolf Herve
    Escudier, Bernard
    Sautes-Fridman, Catherine
    Albiges, Laurence
    Chaput-Gras, Nathalie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (05)
  • [27] TiNivo - tivozanib combined with nivolumab: Safety and efficacy in patients with metastatic renal cell carcinoma (mRCC)
    Barthelemy, P.
    Escudier, B.
    Ravaud, A.
    Negrier, S.
    Needle, M. N.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2018, 29 : 311 - 311
  • [28] Fresh blood Immune cell monitoring in patients treated with nivolumab in the GETUG-AFU26 NIVOREN study: Association with toxicity and treatment outcome
    Desnoyer, A.
    Larive, A.
    Drubay, D.
    Lanoy, E.
    Vano, Y.
    Rioux-Leclercq, N.
    Chouaib, S.
    Beuselinck, B.
    Tantot, F.
    Escudier, B.
    Chaput, N.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2019, 30 : 394 - 394
  • [29] Use of nivolumab (N) and cabozantinib (C) for treatment of the metastatic renal cell carcinoma (mRCC) in the Veneto region: Results of AMOUR study.
    Maruzzo, Marco
    Bortolami, Alberto
    Palleschi, Dario
    Zivi, Andrea
    Nicodemo, Maurizio
    Sartori, Donata
    De Vivo, Rocco
    Zustovich, Fable
    Bimbatti, Davide
    Pastorelli, Davide
    Vultaggio, Giuseppe Dione
    Soraru, Mariella
    Ballestrin, Melissa
    Zanchetta, Giulia
    Modonesi, Caterina
    Randisi, Paola
    Barile, Carmen
    Perri, Gino
    Basso, Umberto
    Zagonel, Vittorina
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [30] Prognosis impact of serous metastases (SMs) in clear cell renal cell carcinoma patients in the GETUG-AFU-26 NIVOREN phase II trial.
    Bardet, Florian
    Dalban, Cecile
    Chevreau, Christine
    Negrier, Sylvie
    Laguerre, Brigitte
    Gravis, Gwenaelle
    Gross-Goupil, Marine
    Oudard, Stephane
    Barthelemy, Philippe
    Ferrero, Jean Marc
    Thiery-Vuillemin, Antoine
    Mahammedi, Hakim
    Narciso, Berangere
    Geoffrois, Lionnel
    Tantot, Florence
    Escudier, Bernard
    Ladoire, Sylvain
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345